C. H. Ashton

3.5k total citations · 1 hit paper
44 papers, 2.5k citations indexed

About

C. H. Ashton is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, C. H. Ashton has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 14 papers in Psychiatry and Mental health and 9 papers in Cognitive Neuroscience. Recurrent topics in C. H. Ashton's work include Pain Mechanisms and Treatments (7 papers), Cannabis and Cannabinoid Research (7 papers) and Pain Management and Treatment (6 papers). C. H. Ashton is often cited by papers focused on Pain Mechanisms and Treatments (7 papers), Cannabis and Cannabinoid Research (7 papers) and Pain Management and Treatment (6 papers). C. H. Ashton collaborates with scholars based in United Kingdom, Spain and Netherlands. C. H. Ashton's co-authors include Farhad Kamali, P. Brian Moore, E Webb, John W. Thompson, Mark I. Johnson, Peter J. Kelly, V. R. Marsh, I. Nicol Ferrier, Selim El-Badri and Allan H. Young and has published in prestigious journals such as The Lancet, Biological Psychiatry and Journal of Applied Physiology.

In The Last Decade

C. H. Ashton

42 papers receiving 2.3k citations

Hit Papers

Pharmacology and effects of cannabis: A brief review 2001 2026 2009 2017 2001 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. H. Ashton United Kingdom 21 1.2k 422 414 376 369 44 2.5k
Marc L. Copersino United States 24 660 0.6× 490 1.2× 444 1.1× 268 0.7× 312 0.8× 42 2.0k
Karen L. Hanson United States 25 611 0.5× 575 1.4× 342 0.8× 154 0.4× 432 1.2× 50 2.3k
Rajiv Radhakrishnan United States 29 1.1k 0.9× 549 1.3× 555 1.3× 210 0.6× 495 1.3× 83 2.5k
Roy J. Mathew United States 35 979 0.8× 712 1.7× 899 2.2× 135 0.4× 449 1.2× 102 3.5k
Marcos Hortes Nisihara Chagas Brazil 29 1.5k 1.3× 594 1.4× 507 1.2× 256 0.7× 535 1.4× 113 3.4k
Suzanne K. Vosburg United States 33 1.2k 1.0× 964 2.3× 408 1.0× 98 0.3× 319 0.9× 68 2.9k
Gerhard A. Wiesbeck Switzerland 34 423 0.4× 776 1.8× 382 0.9× 193 0.5× 591 1.6× 127 3.4k
Anthony Liguori United States 20 827 0.7× 332 0.8× 180 0.4× 95 0.3× 356 1.0× 48 2.0k
Maria A. Sullivan United States 38 939 0.8× 770 1.8× 527 1.3× 138 0.4× 317 0.9× 99 3.5k
José A. Crippa Brazil 24 1.4k 1.2× 619 1.5× 396 1.0× 249 0.7× 390 1.1× 47 2.5k

Countries citing papers authored by C. H. Ashton

Since Specialization
Citations

This map shows the geographic impact of C. H. Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. H. Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. H. Ashton more than expected).

Fields of papers citing papers by C. H. Ashton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. H. Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. H. Ashton. The network helps show where C. H. Ashton may publish in the future.

Co-authorship network of co-authors of C. H. Ashton

This figure shows the co-authorship network connecting the top 25 collaborators of C. H. Ashton. A scholar is included among the top collaborators of C. H. Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. H. Ashton. C. H. Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashton, C. H. & P. Brian Moore. (2011). Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatrica Scandinavica. 124(4). 250–261. 116 indexed citations
2.
Köhler, Sebastian, et al.. (2010). Electrophysiological changes in late life depression and their relation to structural brain changes. International Psychogeriatrics. 23(1). 141–148. 19 indexed citations
3.
Ashton, C. H.. (2001). Pharmacology and effects of cannabis: A brief review. The British Journal of Psychiatry. 178(2). 101–106. 608 indexed citations breakdown →
4.
Ashton, C. H., et al.. (2000). Subchronic hydrocortisone treatment alters auditory evoked potentials in normal subjects. Psychopharmacology. 152(1). 87–92. 6 indexed citations
5.
Young, Allan H., John Hughes, & C. H. Ashton. (2000). Brain 5-HT function in bipolar affective disorder. Acta Neuropsychiatrica. 12(3). 91–95. 2 indexed citations
6.
Ashton, C. H.. (1999). Adverse effects of cannabis and cannabinoids. British Journal of Anaesthesia. 83(4). 637–649. 151 indexed citations
7.
Ashton, C. H.. (1999). Biomedical benefits of cannabinoids?. Addiction Biology. 4(2). 111–126. 17 indexed citations
8.
Webb, E, et al.. (1998). An update on British medical students' lifestyles. Medical Education. 32(3). 325–331. 106 indexed citations
9.
Ashton, C. H., et al.. (1998). Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression. Biological Psychiatry. 44(1). 34–46. 64 indexed citations
10.
Ashton, C. H., et al.. (1997). Therapeutic uses of cannabis. 57 indexed citations
11.
Webb, E, C. H. Ashton, Peter J. Kelly, & Farhad Kamali. (1996). Alcohol and drug use in UK university students. The Lancet. 348(9032). 922–925. 370 indexed citations
12.
Ashton, C. H. & Farhad Kamali. (1995). Personality, lifestyles, alcohol and drug consumption in a sample of British medical students. Medical Education. 29(3). 187–192. 148 indexed citations
13.
Ashton, C. H., et al.. (1994). Biological correlates of deliberate self‐harm behaviour: a study of electroencephalographic, biochemical and psychological variables in parasuicide. Acta Psychiatrica Scandinavica. 90(5). 316–323. 23 indexed citations
14.
Johnson, Mark I., C. H. Ashton, & John W. Thompson. (1992). Long Term Use of Transcutaneous Electrical Nerve Stimulation at Newcastle Pain Relief Clinic. Journal of the Royal Society of Medicine. 85(5). 267–268. 33 indexed citations
15.
Johnson, Mark I., C. H. Ashton, & John W. Thompson. (1991). An in-depth study of long-term users of transcutaneous electrical nerve stimulation (TENS). Implications for clinical use of TENS. Pain. 44(3). 221–229. 120 indexed citations
16.
Johnson, Mark I., C. H. Ashton, & John W. Thompson. (1991). The consistency of pulse frequencies and pulse patterns of transcutaneous electrical nerve stimulation (TENS) used by chronic pain patients. Pain. 44(3). 231–234. 33 indexed citations
18.
Marshall, Elizabeth F., et al.. (1990). Estimation of human blood plasma 5‐hydroxyindoleacetic acid and homovanillic acid. Biomedical Chromatography. 4(5). 201–204. 12 indexed citations
19.
Ashton, C. H., M. D. Rawlins, & Stephen Tyrer. (1990). A Double-Blind Placebo-Controlled Study of Buspirone in Diazepam Withdrawal in Chronic Benzodiazepine Users. The British Journal of Psychiatry. 157(2). 232–238. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026